Research programme: antibody based immune cell engager molecules- LabGenius
Latest Information Update: 03 Nov 2022
At a glance
- Originator LabGenius
- Class Antibodies; Antineoplastics; Immunotherapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 12 Oct 2022 Early research in Cancer in United Kingdom (Parenteral) before October 2022